Gary A. Piazza
Professor
Oncologic Sciences
Mitchell Cancer Institute
United States of America
Biography
Dr. Gary A. Piazza is currently working as Professor at Department of Oncologic Sciences, Mitchell Cancer Institute (USA). He has received his Bachelors from Biology and Psychology, Dominican University and Ph.D in Pharmacology from University of Alabama at Birmingham. Dr.Gary A. Piazza has also been Postdoctoral Fellowship at Fox Chase Cancer Center and Brown University. Dr.Gary A. Piazza has many reviewed publications.
Research Interest
Anticancer activity of nonsteroidal anti-inflammatory drugs; Molecular libraries screening and cellular imaging; Phosphodiesterases; cyclic GMP signaling; and apoptosis; Cancer drug discovery and development
Publications
-
Thompson HJ, Jiang C, Lu J, Mehta RG, Piazza GA, Paranka NS, Pamukcu R, Ahnen DJ. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Cancer research. 1997 Jan 15;57(2):267-71.
-
Thompson WJ, Piazza GA, Li H, Liu L, Fetter J, Zhu B, Sperl G, Ahnen D, Pamukcu R. Exisulind induction of apoptosis involves guanosine 3′, 5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated β-catenin. Cancer research. 2000 Jul 1;60(13):3338-42.
-
Piazza GA, Rahm AK, Finn TS, Fryer BH, Li H, Stoumen AL, Pamukcu R, Ahnen DJ. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. Cancer research. 1997 Jun 15;57(12):2452-9.
-
Piazza GA, Rahm AL, Krutzsch M, Sperl G, Paranka NS, Gross PH, Brendel K, Burt RW, Alberts DS, Pamukcu R, Ahnen DJ. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer research. 1995 Jul 15;55(14):3110-6.
